# guidelines_snapshot_module.py — Diagnoso v2.2

def aha_guidelines():
    return """
- AHA 2024: Start ACE inhibitors, ARNI or ARB in all patients with HFrEF unless contraindicated.
- AHA 2024: SGLT2 inhibitors strongly recommended for all heart failure classes.
- AHA 2024: Beta blockers (Metoprolol succinate, Carvedilol) mandatory unless contraindicated.
- AHA 2024: Diuretics for symptomatic fluid overload.
- AHA 2024: Avoid non-dihydropyridine CCBs in HFrEF.
"""

def esc_guidelines():
    return """
- ESC 2024: STEMI — PCI door-to-balloon < 90 minutes critical.
- ESC 2024: NSTEMI — High-sensitivity troponin recommended at 0 and 1 hour.
- ESC 2024: Dual antiplatelet for 12 months post-PCI.
- ESC 2024: Echocardiogram mandatory for all ACS with LV dysfunction.
"""

def ada_guidelines():
    return """
- ADA 2025: Metformin first-line unless contraindicated.
- ADA 2025: Early SGLT2i or GLP-1 RA for ASCVD, HF, or CKD patients.
- ADA 2025: HbA1c target individualized — general goal < 7%.
- ADA 2025: New obesity pharmacotherapy agents incorporated into algorithm.
"""

def idsa_guidelines():
    return """
- IDSA 2024: CAP — Amoxicillin 1g TID or Doxycycline 100mg BID outpatient.
- IDSA 2024: HAP/VAP — Piperacillin-Tazobactam + Vancomycin until cultures available.
- IDSA 2024: PJP — TMP-SMX 15-20 mg/kg/day divided doses.
- IDSA 2024: Sepsis — Broad-spectrum antibiotics within 60 minutes.
"""

def ats_guidelines():
    return """
- ATS 2024: ARDS — Lung protective ventilation 4-6 ml/kg PBW.
- ATS 2024: Prone positioning improves mortality in moderate-to-severe ARDS.
- ATS 2024: Conservative fluid strategy preferred once hemodynamically stable.
"""

def eular_guidelines():
    return """
- EULAR 2024: RA — Early DMARD initiation, Methotrexate first-line.
- EULAR 2024: Steroids tapered within 3-6 months.
- EULAR 2024: Biologic initiation after MTX failure.
"""

def kdigo_guidelines():
    return """
- KDIGO 2024: Start SGLT2 inhibitors in CKD patients stage 3-4.
- KDIGO 2024: Blood pressure target <130/80 in most CKD.
- KDIGO 2024: Avoid NSAIDs in CKD unless essential.
- KDIGO 2024: Statins recommended for proteinuric CKD.
"""

def gold_guidelines():
    return """
- GOLD 2024: ABCD groups replaced by simplified personalized assessment.
- GOLD 2024: LAMA or LABA initial therapy in most COPD patients.
- GOLD 2024: ICS reserved for frequent exacerbators or high eosinophils.
- GOLD 2024: Smoking cessation is cornerstone of COPD management.
"""

def jnc_guidelines():
    return """
- JNC 8: BP target <140/90 generally.
- JNC 8: For diabetes or CKD: <130/80 may be reasonable.
- JNC 8: Thiazide diuretics, ACEi, ARBs, or CCBs are first-line.
"""

def chest_guidelines():
    return """
- CHEST 2024: DVT/PE — DOACs first-line unless contraindicated.
- CHEST 2024: Submassive PE — Consider catheter-directed therapy in select cases.
- CHEST 2024: Anticoagulation minimum 3 months, longer if provoked.
"""

def nccn_guidelines():
    return """
- NCCN 2024: Lung — Nivolumab + chemo for stage 3 NSCLC.
- NCCN 2024: Breast — Endocrine therapy duration individualized beyond 5 years.
- NCCN 2024: Colon — ctDNA now part of post-op risk stratification.
"""

def asco_guidelines():
    return """
- ASCO 2024: Immunotherapy first-line in many advanced cancers.
- ASCO 2024: Liquid biopsies emerging but not yet standard everywhere.
- ASCO 2024: Incorporate palliative care early in metastatic disease.
"""

def bts_guidelines():
    return """
- BTS 2024: CAP — Oral amoxicillin 1g TID or doxycycline 200mg loading then 100mg BID.
- BTS 2024: Repeat CXR in 6 weeks if concern for underlying malignancy.
- BTS 2024: Avoid routine macrolide dual therapy unless comorbid.
"""

def nice_guidelines():
    return """
- NICE 2024: Early antibiotics in suspected sepsis prioritized.
- NICE 2024: Antenatal corticosteroids recommended <34 weeks if preterm labor.
- NICE 2024: CKD — SGLT2 inhibitors and ACEi/ARB strongly advised.
"""

def who_guidelines_extended():
    return """
- WHO 2024: Antibiotics within 1 hour for sepsis.
- WHO 2024: Dexamethasone 6mg daily for severe COVID.
- WHO 2024: TMP-SMX 15-20 mg/kg/day for PJP.
- WHO 2024: Essential Medicines List fully updated.
"""
